Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jan 21;2009(1):CD006736.
doi: 10.1002/14651858.CD006736.pub2.

Iron supplementation for reducing morbidity and mortality in children with HIV

Ifedayo Adetifa  1 , Uduak Okomo
Affiliations

Iron supplementation for reducing morbidity and mortality in children with HIV

Ifedayo Adetifa et al. Cochrane Database Syst Rev. .

Abstract

Background: The most prevalent haematologic disturbance associated with HIV in children (apart from CD4 lymphocytopenia) is anaemia. Anaemia associated with HIV arises from multiple mechanisms, including the direct inhibitory effect of HIV on red cell precursors, other locally prevalent and/or opportunistic infections, micronutrient deficiency, anaemia of chronic disease, and as a consequence of medicines given for HIV and/or other concurrent illnesses. Iron deficiency is the most common cause of nutritional anaemia globally. There is significant geographical overlap of areas of the world where iron deficiency anaemia (IDA) and paediatric HIV are distributed. Given the high prevalence of IDA, it is likely that many HIV-infected children also are iron deficient. The contribution of iron deficiency to anaemia in HIV-infected children has been described but is incompletely understood. Currently, iron supplementation for anaemic infants and children is routinely practiced without any obvious effect in most developing countries, which bear most of the burden of global paediatric HIV infections.Because iron deficiency and IDA are common in HIV-infected children in high-prevalence areas and because there are concerns about possible deleterious effects of iron, this review aims to assess the evidence for iron supplementation for reducing morbidity and mortality in HIV-infected children.

Objectives: To determine whether iron supplementation improves clinical, immunologic, and virologic outcomes in children infected with HIV SEARCH STRATEGY: We used the comprehensive search strategy developed specifically by the Cochrane HIV/AIDS Review Group to identify HIV/AIDS randomised controlled trials, and searched the following electronic databases: MEDLINE (searched November 2007); Embase (searched December 2007); and CENTRAL (December 2007). This search was supplemented with a search of AIDSearch (searched December 2007) and NLM Gateway (searched December 2007) to identify relevant conference abstracts, as well as a search of the reference lists of all eligible articles. The search was not limited by language or publication status.

Selection criteria: Randomised controlled trials (RCTs) of iron supplementation in any form and dose in HIV-infected children aged 12 years and younger.

Data collection and analysis: We independently screened the results of the search to select potentially relevant studies and to retrieve the full articles. We independently applied the inclusion criteria to the potentially relevant studies. No studies were identified that fulfilled the selection criteria.

Main results: No RCTs of iron supplementation in HIV-infected children were found.

Implications for clinical practice: The current clinical practice of iron supplementation in HIV-infected children is based on weak evidence comprising observational studies and expert opinions.

Implications for research: High-quality RCTs of iron supplementation are urgently required, especially in areas with significant overlap of high prevalence of HIV, iron deficiency anaemia, and malaria. Policy makers should prioritise funding for these trials.

PubMed Disclaimer

Conflict of interest statement

None

Update of

  • doi: 10.1002/14651858.CD006736

References

References to studies excluded from this review

Jacobus 1996 {published data only}
    1. Jacobus DP. Randomization to iron supplementation of patients with advanced human immunodeficiency virus disease‐an inadvertent but controlled study with results important for patient care. J Infect Dis 1996;173:1044‐5. - PubMed
Olsen 2004 {published data only}
    1. Olsen A, Mwaniki D, Krarup H, Friis H. Low‐dose iron supplementation does not increase HIV‐1 load. Journal of Acquired Immune Deficiency Syndrome 2004;36(1):637‐638. - PubMed
Olsen 2006 {published data only}
    1. Olsen A, Nawiri J, Magnussen P, Krarup H, Friis H. Failure of twice‐weekly iron supplementation to increase blood haemoglobin and serum ferritin concentrations: results of a randomized controlled trial. Annals of Tropical Medicine and Parasitology 2006;100(3):251‐263. - PubMed
Semba 2007 {published data only}
    1. Semba RD, Ricketts EP, Mehta S, Netski D, Thomas D, Kirk G. Eefect of micronutrients and iron supplementation on haemoglobin, iron status, and plasma hepatitis C and HIV RNA levels in female injection drug users: a controlled clinical trial. J Acquir Immune Defic Syndr 2007;45:298‐303. - PubMed

Additional references

Adetifa 2006
    1. Adetifa IMO, Temiye EO, Akinsulie AO, Ezeaka VC, Iroha EO. Haematolgical abnormalities associated with paediatric HIV/AIDS in Lagos. Annals Tropical Paediatrics 2006;26:121‐125. - PubMed
Adewuyi 1994
    1. Adewuyi J, Chitsike I. Haematologic features of the human immunodeficiency virus (HIV) infection in black children in Harare. Central Africa Journal of Medicine 1994;40:333‐336. - PubMed
Afacan 2002
    1. Afacan YE, Hasan MS, Omene JA. Iron deficiency anaemia in HIV infection: immunologic and virologic response. Journal of the National Medical Association 2002;94(2):73‐7. - PMC - PubMed
Allen 1998
    1. Allen UD, King SM, Gomez MP, et al. Serum immunoreactive erythropoietin levels and associated factors amongst HIV‐infected children. AIDS 1998;12:1785‐1791. - PubMed
Berhane 2004
    1. Berhane K, Karim R, Cohen MH, Masri‐Lavine L, Young M, Anastos K, Augenbraun M, WattsDH, Levine AM. Impact of highly active antiretroviral therapy on anaemia and relationship between anaemia and survival in a large cohort of HIV‐infected women: Women's Interagency HIV Study. J Acquir Immune Defic Syndr 2004;37:1245‐52. - PubMed
Boelaert 1996
    1. Boelaert JR, Weinberg GA, Weinberg ED. Altered iron metabolism in HIV infection:mechanisms, possible consequences, and proposals for management. Infect Agents Dis 1996;5:36‐46. - PubMed
Butler 1991
    1. Butler KM, Husson RN, Balis FM, et al. Dideoxyinosine in children with symptomatic HIV infection. New England Journal of Medicine 1991;324:137‐144. - PubMed
Carr 1998
    1. Carr JM, Ramshaw HS, Li P, Burrell CJ. CD34+ cells and their derivatives contain mRNA for CD4 and HIV co‐receptors and are susceptible to infection with M‐ and T‐topic HIV. Journal of General Virology 1998;79:71‐75. - PubMed
CDC 1994
    1. Centres for Disease Control and Prevention. 1994 revised classification for human immunodeficiency virus infection in children less than 13 years of age.. Morbidity and Mortality Weekly Review 1994;43(RR‐12):1‐10.
Clark 2001
    1. Clark TD, Semba RD. Iron supplementaion during human immunodeficiency virus infection: a double‐edged sword?. Med Hypotheses 2001;57(4):476‐9. - PubMed
Clark 2002
    1. Clark TD, Mmiro F, Ndugwa C, et al. Risk factors and cummulative incidence of anaemia among human immunodeficiency virus‐infected children in Uganda. Annals of Tropical Paediatrics 2002;22:11‐17. - PubMed
Costagliola 1994
    1. Costagliola DG, Montalembert M, Lefrere JJ. Dose of deferroxamine and evolution of HIV‐1 infection in thalassaemic patients. British Journal of Hematology 1994;87:849‐852. - PubMed
Coyle 1997
    1. Coyle TE. Hematologic complications of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Med Clin N Am 1997;81:449‐470. - PubMed
De Monye 1999
    1. Monye C, Karcher DS, Boelaert JR, Gordeux VR. Bone marrow macrophage iron grade and survival of HIV‐seropositive patients. Acquired Immune Deficiency Syndrome 1999;13:375‐380. - PubMed
Delanghe 1998
    1. Delanghe JR, Langlois MR, Boelaert JR. Haptoglobin polymorphism, iron metabolism and mortality in HIV infection. Acquired Immune Deficiency Syndrome 1998;12:1027‐1032. - PubMed
Eley 2002
    1. Eley BS, Sive AA, Shuttleworth M, Hussey GD. A prospective, cross‐sectional study of anaemia and peripheral iron status in antiretroviral naive, HIV‐1 infected children in Cape Town, South Africa. BMC Infectious Diseases 2002;2(3). - PMC - PubMed
Ellaurie 1990
    1. Ellaurie M, Burn ER, Rubinstein A. Haematologic manifestations in paediatric HIV infection:severe anaemia as a prognostic factor.. Am J Pediatr Hematol Oncol 1990;12:449‐453. - PubMed
Feelders 1999
    1. Feelders RA, Kuiper EPA‐Kramer, Eijk HG. Structure, function and clinical significance of transferrin receptors. Clin Chem Lab Med 1999;37:1‐10. - PubMed
Forsyth 1996
    1. Forsyth BN, Andiman WA, O'Connor T. Development of a prognosis based clinical staging system for infants infected with human immunodefiency virus. J Pediatr 1996;129:648‐655. - PubMed
Fraser 2006
    1. Fraser A, Bilenko N, Paul M, Leibovici L, Fraser D. Supplementation with two or more micronutrients versus single micronutrient supplementation or placebo in young children. Cochrane Database of Systematic Reviews 2006, Issue 2.
Friis 2005
    1. Friis H. Micronutrients and HIV infection: a review of current evidence. Consultation on Nutrition and HIV/AIDS in Africa: evidence, lessons and recommedations for action. World Health Organization. Department of Nutrition for Health and Development. World Health Organization. Geneva, 2005:1‐28.
Geissler 1991
    1. Geissler RG, Ottman OG, Eder M, Kojouharoff G, Hoelzer D, Ganser A. Effect of recombinant human transforming growth factor beta and tumour necrosis factor alpha on bone marrow progenitor cells of HIV‐infected persons. Ann Hematol 1991;62:151‐155. - PubMed
Gordeuk 2006
    1. Gordeuk VR, Onojobi G, Schneider MF, Dawkins FW, Delapenha R, Voroshin Y, Wyl V, Bacon M, Minkoff H, Levine A, Cohen M, Greenblatt RM. The association of serum ferritin and transferrin receptor concentrations with mortality in women with human immunodeficiency virus infection. Haematologica 2006;91:739‐43. - PubMed
Gordeux 2001
    1. Gordeux VR, Delanghe JR, Langlois MR, Boelaert JF. Iron status and the outcome of HIV infection: an overview. J Clin Virol 2001;20:111‐5. - PubMed
Iannotti 2006
    1. Iannotti LL, Tielsch JM, Black MM, Black RE. Iron supplementation in early childhood: heatlh benefits and risks. American Journal of Clinical Nutrition 2006;84:1261‐1276. - PMC - PubMed
Kupka 2007
    1. Kupka R, Msamanga GI, Mugusi F, Petraro P, Hunter DJ, Fawzi WW. Iron status is an important cause of anaemia in HIV infected Tanzanian women but is not related to accelerated HIV disease progression. J Nutr 2007;137:2317‐23. - PubMed
Martins 2001
    1. Martins S, Logan S, Gilbert R. Iron supplementation for improving psychomotor development and cognitive function in infants under the age of one. Cochrane Database of Systematic Reviews 2001, Issue 2. - PubMed
McDermid 2007
    1. McDermid JM, Jaye A, Schim van der Loeff MF, Todd J, Austin S, Jeffries D, Awasana AA, Whittlex AA, Prentice AA. Elevated iron status strongly predicts mortality in West African adults with HIV infection. J Acquir Immune Defic Syndrom 2007;46:498‐507. - PubMed
Moore 1999
    1. Moore RD. Human immunodeficiency virus infection, anaemia and survival. Clin Infect Dis 1999;29:44‐9. - PubMed
Moses 1996
    1. Moses AV, Williams S, Heneveld ML. Human immunodeficiency virus infection of the bone marrow epithelium reduces induction of stromal hematopoietic growth factors. Blood 1996;87:919‐925. - PubMed
Ojukwu 2007
    1. Ojukwu JU, Okebe JU. Routine iron supplementation for preventing or treating iron‐deficiency anaemia in children in malaria‐endemic areas. Cochrane Database of Systematic Reviews 2007, Issue 3. - PubMed
Olsen 2004
    1. Olsen A, Mwanniki D, Krarup H, Friis H. Low‐dose iron supplementation does not increase HIV‐1 load. J Acquir Immune Defic Syndr 2004;36:637‐638. - PubMed
Pizzo 1988
    1. Pizzo PA, Eddy J, Falloon J, et al. Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection. N Engl J Med 1988;319:889‐896. - PubMed
Richman 1987
    1. Richman D, AZT Collaborative Working Group. The toxicity of azidothymidine in the treatment of patients with AIDS and AIDS‐related complex. N Engl J Med 1987;317:192. - PubMed
Sahli 1998
    1. Sahli Y, Costagliola DG, Rebulla P, et al. Serum ferritin, desferrioxamine, and evolution of HIV‐1 infection in thalassemic patients.. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18:473‐8. - PubMed
Salmon‐Ceron 1995
    1. Salmon‐Ceron D, Fontbonne A, Saba J. Lower survival in AIDS patients receiving dapsone compared with aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia. J Infect Dis 1995;172:656‐664. - PubMed
Savarino 1999
    1. Savarino A, Pescarmona GP, Boelaert JR. Iron metabolism and HIV infection:reciprocal interactions with potentially harmful consequences?. Cell Biochem Funct 1999;17:279‐287. - PubMed
Schwartz 1994
    1. Schwartz GN, Kessler SW, Rothwell SW. Inhibitory effects of HIV‐1‐infected stromal cell layers on production of myeloid progenitor cels in human long‐term bone marrow cultures. Exp Hematol 1994;22:1288‐1296. - PubMed
Semba 2003
    1. Semba RD. Iron‐deficiency anaemia and the cycle of poverty among human imunodeficiency virus‐infected women in the inner city. Clin Infect Dis 2003;37(Suppl 2):S105‐11. - PubMed
Semba 2000
    1. Semba RD, Kumwenda N, Hoover DR, Taha TE, Mtimavalye L, Broadhead R, Eisinger W, Miotti PG, Chiphangwi JD. Assessment of iron status using plasma transferrin receptor in pregnant women with and without human immunodeficiency virus infection in Malawi. Eur J Clin Nutr 2000;54:872‐7. - PubMed
Semba 2001
    1. Semba RD, Gray GE. The pathogenesis of anaemia during human immunodeficiency virus infection. J Invest Med 2001;49:225‐239. - PubMed
Semba 2007
    1. Semba RD, Ricketts EP, Mehta S, Netski D, Thomas D, Kirk G, Wu AW, Vlahov D. Effect of micronutrients and riron supplementation on haemoglobin, iron status, and plasma hepatitis C and HIV RNA levels in female injection drug users: a controlled clinical trial. J Acquir Immune Defic Syndr 2007;45:298‐303. - PubMed
Totin 2002
    1. Totin D, Ndugwa C, Mmiro F, Perry RT, Jackson JB, Semba RD. Iron deficiency anaemia is highly prevalent among human immunodeficiency virus‐infected and uninfected infants in Uganda. J Nutr 2002;132:423‐9. - PubMed
UNICEF 1998
    1. UNICEF/UNU/WHO/MI. Preventing iron deficiency in women and children: background and consensus on key technical issues and resources for advocacy, planning, and implementing national programs. UNICEF/UNU/WHO/MI Technical Workshop, 1998. Geneva.
Volberding 2000
    1. Volberding P. Consensus statement:anaemia in HIV infection‐current trends, treatment options, and practice strategies. Clin Ther 2000;22:1004‐1020. - PubMed
Vorster 2004
    1. Vorster HH, KrugerA, Margetts BM, et al. The nutritional status of asymptomatic HIV‐infected Africans:directions for dietary intervention?. Public Health Nutrition 2004;7(8):1055‐1064. - PubMed
Weinberg 1996
    1. Weinberg GA. Iron overload as a mechanism for the lowered survival in AIDS patients receiving dapsone‐iron protoxolate for secondary prophylaxis of Pneumocystis carinii pneumonia. J Infect Dis 1996;174:241‐2. - PubMed
Weinberg 2001
    1. Weinberg GA, Friis H, Boelaert JR, Weinberg ED. Iron status and the severity of HIV infection in pregnant women. Clin Infect Dis 2001;33:2098‐9. - PubMed
WHO 2001
    1. UNICEF/WHO/UNU. Iron Deficiency Anaemic‐Assessment, Prevention, and Control. A guide for programme Managers. http//:www.who.int/nutrition/publications/en/ida_assessment_prevention_control.pdf. 2001.
WHO 2006
    1. World Health Organization. Antiretroviral therapy of HIV infection in infants and children in resource limited settings:towards universal access. Recommendations for a public health approach. Geneva, 2006. - PubMed
Xiaoxi 2007
    1. Xiaoxi Z, Wu T. Iron supplementation for iron deficiency anaemia in children. Cochrane Database of Systematic Reviews 2007, Issue 2. [CD006465]
Zauli 1996
    1. Zauli G, Vitale M, Gibellini D, Capitani S. Inhibition of purified CD34+ hematopoietic progenitor cells by human immunodeficiency virus‐1 or gp120 mediated by endogenous transforig growth factor beta‐1. J Exp Med 1996;183:99‐108. - PMC - PubMed
Zauli 1994
    1. Zauli G, Furlini G, Vitale M. A subset of human CD34+ haematopoietic progenitors express low levels of CD4, the high affinity receptor for human immunodeficiency virus‐type 1. Blood 1994;84:1896‐1905. - PubMed
Zon 1988
    1. Zon LI, Groopman J. Hematologic manifestations of the human immune deficiency virus (HIV). Seminars in Hematology 1988;25(3):208‐218. - PubMed

Publication types